2012-13 NHIS, BRFSS, and NIS-Flu Influenza Data
The National Health Interview Survey (NHIS) is the data source used to monitor Healthy People 2020 objectives for influenza vaccination (IID-12.11-13). Influenza vaccination coverage estimates nationally and by state and selected local area from NIS-Flu and BRFSS are available each season approximately eleven months before final national estimates from NHIS. A comparison of national estimates from NIS-Flu and BRFSS to NHIS is available below for the 2012-13 season. Additional information on methods is available at Surveillance of Influenza Vaccination Coverage — United States, 2007–08 Through 2011–12 Influenza Seasons.
Table 1. Influenza vaccination coverage* by age group, and race/ethnicity, children 6 months through 17 years, National Health Interview Survey (NHIS) and National Immunization Survey-Flu (NIS-Flu), United States,† 2012-13 influenza season
Total | Change from 2011-12|| to 2012-13 influenza season (percentage points) |
White only, non-Hispanic |
Black only, non-Hispanic |
Hispanic | Other, non-Hispanic¶ |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Surveillance System | Unweighted Sample Size | %‡ | 95% CI§ | % | 95% CI§ | % | 95% CI§ | % | 95% CI§ | % | 95% CI§ | |
NHIS | ||||||||||||
Age Group | ||||||||||||
6 months-17 years |
8,658 |
50.5 | ± 1.8 |
3.4 |
47.8 | ± 2.5 | 49.6 | ± 4.5 | 53.6 | ± 2.9 | 58.7 | ± 5.3 |
6-23 months |
811 |
69.2 | ± 5.9 |
1.2 |
64.3 | ± 8.2 | 88.1 | ± 14.9 | 67.7 | ± 10.0 | 79.7 | ± 13.9 |
2-4 years |
1,547 |
60.1 | ± 4.3 |
-0.3 |
58.5 | ± 6.1 | 53.9 | ± 14.3 | 60.5 | ± 7.4 | 73.8 | ± 15.3 |
5-12 years |
3,707 |
49.2 | ± 2.4 |
2.4 |
46.2 | ± 3.3 | 50.0 | ± 7.3 | 52.9 | ± 4.1 | 56.1 | ± 7.1 |
13-17 years |
2,593 |
40.8 | ± 3.3 |
6.0 |
39.4 | ± 4.9 | 35.3 | ± 7.6 | 44.3 | ± 5.5 | 47.2 | ± 10.4 |
NIS-Flu | ||||||||||||
Age Group | ||||||||||||
6 months-17 years |
100,829 |
56.6 | ± 0.9 |
5.1 |
53.8 | ± 1.0 | 56.7 | ± 2.7 | 60.9 | ± 2.2 | 60.8 | ± 2.7 |
6-23 months |
10,632 |
76.9 | ± 2.3 |
2.3 |
75.5 | ± 2.5 | 75.8 | ± 7.9 | 79.8 | ± 5.3 | 77.4 | ± 5.6 |
2-4 years |
18,082 |
65.8 | ± 2.0 |
2.5 |
63.9 | ± 2.4 | 63.3 | ± 5.9 | 69.3 | ± 4.5 | 68.6 | ± 5.6 |
5-12 years |
47,526 |
58.6 | ± 1.3 |
4.4 |
55.9 | ± 1.4 | 58.4 | ± 3.8 | 62.1 | ± 3.2 | 64.5 | ± 3.7 |
13-17 years |
24,589 |
42.5 | ± 1.5 |
8.8 |
41.4 | ± 1.7 | 44.1 | ± 4.5 | 45.1 | ± 4.1 | 42.1 | ± 4.5 |
Difference Percent Vaccinated, NIS-Flu -NHIS | ||||||||||||
Age Group | ||||||||||||
6 months-17 years | 6.1** | ± 2.0 | 6.0** | ± 2.2 | 7.1** | ± 5.2 | 7.3** | ± 3.6 | 2.1 | ± 5.9 | ||
6-23 months | 7.7** | ± 6.3 | 11.2** | ± 8.6 | -12.3 | ± 16.1 | 12.1** | ± 11.3 | -2.3 | ± 14.2 | ||
2-4 years | 5.7** | ± 4.7 | 5.4 | ± 6.6 | 9.4 | ± 15.2 | 8.8** | ± 8.7 | -5.2 | ± 16.0 | ||
5-12 years | 9.4** | ± 2.7 | 9.7** | ± 3.6 | 8.4** | ± 8.2 | 9.2** | ± 5.2 | 8.4** | ± 8.0 | ||
13-17 years | 1.7 | ± 3.6 | 2.0 | ± 5.2 | 8.8 | ± 8.8 | 0.8 | ± 6.9 | -5.1 | ± 11.0 |
* Estimates of the percentage of people vaccinated are based on interviews conducted beginning September (NHIS) or October (NIS-Flu) 2012 through June 2013 and reported vaccinations from July 2012 through May 2013.
† Excludes U.S. territories.
‡ Percentage Vaccinated. Percentages are weighted to the non-institutionalized, U.S. civilian population. Month of vaccination was imputed for respondents with missing month of vaccination data.
§ Confidence interval half-widths.
|| Estimates of the percentage of people vaccinated based on interviews conducted September (NHIS) or October (NIS-Flu) 2011 through June 2012 and reported vaccinations from August 2011 through May 2012.
¶ Includes Asian, American Indian/Alaska Native (AI/AN), and multiple races.
** Statistically significant difference between the 2012-13 NIS-Flu and the 2012-13 NHIS season by t-test (P<0.05).
Table 2. Influenza vaccination coverage* by age group, high-risk status,† and race/ethnicity, adults 18 years and older, Behavioral Risk Factor Surveillance System (BRFSS) and National Health Interview Survey (NHIS), United States,‡ 2012-13 season
Total | Change from 2011-12¶ to 2012-13 influenza season (percentage points) |
White only, non-Hispanic |
Black only, non-Hispanic |
Hispanic | Other, non-Hispanic** |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Surveillance System | Unweighted Sample Size | %§ | 95% CI|| | % | 95% CI|| | % | 95% CI|| | % | 95% CI|| | % | 95% CI|| | |
NHIS | ||||||||||||
Age Group | ||||||||||||
≥18 years |
27,717 |
42.6 | ± 1.0 |
3.4 |
46.5 | ± 1.4 | 33.5 | ± 2.7 | 30.6 | ± 2.2 | 46.8 | ± 3.1 |
18-64 years |
21,609 |
36.1 | ± 1.2 |
3.5 |
38.9 | ± 1.6 | 29.5 | ± 2.9 | 27.1 | ± 2.2 | 43.0 | ± 3.5 |
18-64 years with high-risk conditions |
4,306 |
49.5 | ± 2.4 |
4.8 |
49.0 | ± 2.9 | 45.8 | ± 6.7 | 49.4 | ± 5.9 | 63.5 | ± 9.2 |
18-64 years without high-risk conditions |
17,265 |
32.9 | ± 1.2 |
3.9 |
36.2 | ± 1.6 | 25.5 | ± 2.7 | 23.2 | ± 2.4 | 39.3 | ± 3.9 |
18-49 years |
14,575 |
30.5 | ± 1.4 |
3.4 |
32.2 | ± 2.0 | 26.4 | ± 3.1 | 24.1 | ± 2.5 | 40.1 | ± 4.1 |
18-49 years with high-risk conditions |
2,016 |
39.0 | ± 3.3 |
3.1 |
36.6 | ± 3.9 | 40.5 | ± 8.6 | 39.7 | ± 8.2 | 58.7 | ± 13.9 |
18-49 years without high-risk conditions |
12,541 |
29.3 | ± 1.4 |
4.2 |
31.4 | ± 2.0 | 24.3 | ± 3.3 | 22.3 | ± 2.5 | 38.1 | ± 4.5 |
50-64 years |
7,034 |
48.0 | ± 2.0 |
3.3 |
50.7 | ± 2.4 | 36.9 | ± 4.9 | 39.2 | ± 5.1 | 51.7 | ± 7.1 |
≥65 years |
6,108 |
71.6 | ± 2.0 |
1.5 |
73.6 | ± 2.4 | 59.2 | ± 5.7 | 64.3 | ± 6.5 | 72.5 | ± 9.4 |
BRFSS | ||||||||||||
Age Group | ||||||||||||
≥18 years |
348,686 |
41.5 | ± 0.4 |
2.7 |
44.6 | ± 0.4 | 35.6 | ± 1.6 | 33.8 | ± 1.8 | 41.6 | ± 2.2 |
18-64 years |
232,856 |
35.7 | ± 0.6 |
2.6 |
37.5 | ± 0.6 | 32.6 | ± 1.8 | 31.4 | ± 1.8 | 38.7 | ± 2.4 |
18-64 years with high-risk conditions |
61,072 |
45.4 | ± 1.2 |
1.6 |
46.2 | ± 1.2 | 43.5 | ± 3.5 | 45.0 | ± 4.3 | 46.4 | ± 4.5 |
18-64 years without high-risk conditions |
169,331 |
32.9 | ± 0.6 |
2.5 |
34.9 | ± 0.6 | 28.6 | ± 2.0 | 28.2 | ± 2.0 | 37.0 | ± 2.7 |
18-49 years |
120,286 |
31.1 | ± 0.8 |
2.5 |
32.1 | ± 0.8 | 29.3 | ± 2.2 | 28.8 | ± 2.2 | 35.7 | ± 2.7 |
18-49 years with high-risk conditions |
21,768 |
38.1 | ± 1.8 |
2.4 |
37.7 | ± 2.0 | 37.5 | ± 5.5 | 40.3 | ± 5.3 | 40.6 | ± 6.5 |
18-49 years without high-risk conditions |
97,149 |
29.8 | ± 0.8 |
2.0 |
31.1 | ± 0.8 | 27.3 | ± 2.4 | 26.7 | ± 2.4 | 35.2 | ± 3.1 |
50-64 years |
112,570 |
45.1 | ± 0.8 |
2.4 |
46.2 | ± 0.8 | 40.3 | ± 2.5 | 42.5 | ± 3.5 | 48.9 | ± 3.9 |
≥65 years |
115,830 |
66.2 | ± 0.8 |
1.3 |
67.9 | ± 0.8 | 54.5 | ± 3.3 | 65.8 | ± 5.3 | 64.4 | ± 4.7 |
Difference in percent vaccinated, BRFSS – NHIS | ||||||||||||
Age Group | ||||||||||||
≥18 years | -1.1†† | ± 1.1 | -1.9†† | ± 1.5 | 2.1 | ± 3.1 | 3.2†† | ± 2.8 | -5.2†† | ± 3.8 | ||
18-64 years | -0.4 | ± 1.3 | -1.4 | ± 1.7 | 3.1 | ± 3.4 | 4.3†† | ± 2.8 | -4.3†† | ± 4.2 | ||
18-64 years with high-risk conditions | -4.1†† | ± 2.7 | -2.8 | ± 3.1 | -2.3 | ± 7.6 | -4.4 | ± 7.3 | -17.1†† | ± 10.2 | ||
18-64 years without high-risk conditions | 0.0 | ± 1.3 | -1.3 | ± 1.6 | 3.1 | ± 3.4 | 5.0†† | ± 3.1 | -2.3 | ± 4.7 | ||
18-49 years | 0.6 | ± 1.6 | -0.1 | ± 2.2 | 2.9 | ± 3.1 | 4.7†† | ± 3.3 | -4.4 | ± 4.9 | ||
18-49 years with high-risk conditions | -0.9 | ± 3.8 | 1.1 | ± 3.6 | -3.0 | ± 10.2 | 0.6 | ± 9.8 | -18.1†† | ± 14.5 | ||
18-49 years without high-risk conditions | 0.5 | ± 1.6 | -0.3 | ± 2.2 | 3.0 | ± 4.1 | 4.4†† | ± 3.5 | -2.9 | ± 5.5 | ||
50-64 years | -2.9†† | ± 2.2 | -4.5†† | ± 2.5 | 3.4 | ± 4.9 | 3.3 | ± 5.1 | -2.8 | ± 7.2 | ||
≥65 years | -5.4†† | ± 2.2 | -5.7†† | ± 2.5 | -4.7 | ± 5.7 | 1.5 | ± 6.5 | -8.1 | ± 9.4 |
* Estimates of the percentage of people vaccinated are based on interviews conducted beginning September 2012 through June 2013 and reported vaccinations from July 2012 through May 2013.
† High-risk definition based on the NHIS: adults categorized as at high risk for influenza-related complications self-reported 1 or more of the following: (1) ever being told by a physician they had diabetes, emphysema, chronic obstructive pulmonary disease, coronary heart disease, angina, heart attack, or other heart condition; (2) having a diagnosis of cancer during the preceding 12 months (excluding nonmelanoma skin cancer) or ever being told by a physician they have lymphoma, leukemia, or blood cancer during the previous 12 months; (3) being told by a physician they have chronic bronchitis or weak or failing kidneys; or (4) reporting an asthma episode or attack during the preceding 12 months. High-risk definition based on the BRFSS includes adults with diabetes, asthma, myocardial infarction, coronary heart disease, chronic obstructive pulmonary disease (COPD), or cancer (excluding skin cancer).
‡ Excludes U.S. territories.
§ Percentage Vaccinated. Percentages are weighted to the non-institutionalized, U.S. civilian population. Month of vaccination was imputed for respondents with missing month of vaccination data.
|| Confidence interval half-widths.
¶ Estimates of the percentage of people vaccinated based on interviews conducted September 2011 through June 2012 and reported vaccinations from August 2011 through May 2012.
** Includes Asian, American Indian/Alaska Native (AI/AN), and multiple races.
†† Statistically significant difference between the 2012-13 BRFSS and the 2012-13 NHIS season by t-test (P<0.05).
- Page last reviewed: September 11, 2014
- Page last updated: September 11, 2014
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs